This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring
THE SPRINGTIME PARTNERING EVENT
March 18–20, 2024 | Barcelona, SpainMarch 26–27, 2024 | Digital Partnering

NanoMedSyn

Profile

NanoMedSyn develops proprietary vectors for drug delivery and protein degraders. Our drug-engineering platform is using a membrane receptor for endocytosis and degradation of pathogenic proteins in lysosomes. Applications concern immunotherapies of cancers, inflammatory and autoimmunes diseases.